Premium
CARDIAC DISEASE PREDICTION FOLLOWING H ODGKIN LYMPHOMA: AN EORTC LYMPHOMA GROUP AND GELA FOLLOW‐UP STUDY
Author(s) -
Maraldo M.V.,
Giusti F.,
Kaaij M.A.,
HenryAmar M.,
Aleman B.,
Raemaekers J.,
Meijnders P.,
Moser E.C.,
KluinNelemans H.C.,
Spina M.,
Ferme C.,
Fortpied C.,
Specht L.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_34
Subject(s) - medicine , hazard ratio , proportional hazards model , confidence interval , lymphoma , cumulative incidence , cohort , cancer , oncology , hodgkin lymphoma , surgery
174 CARDIAC DISEASE PREDICTION FOLLOWING HODGKIN LYMPHOMA: AN EORTC LYMPHOMA GROUP AND GELA FOLLOW‐UP STUDY M.V. Maraldo* | F. Giusti | M.A. van der Kaaij | M. Henry‐Amar | B. Aleman | J. Raemaekers | P. Meijnders | E.C. Moser | H.C. Kluin‐Nelemans | M. Spina | C. Ferme | C. Fortpied | L. Specht Department of Clinical Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Statistics, EORTC Headquarters, Brussels, Belgium; Department of Internal Medicine, VU University Medical Centre, Amsterdam, Netherlands; Centre de Traitement des Données du Cancéropôle Nord‐Ouest, Centre François Baclesse, Caen, France; Department of Radiation Oncology, the Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands; Department of Radiation Oncology, Iridium Cancer Network, University of Antwerp, Antwerp, Belgium; Department of Radiation Oncology, Champalimaud Cancer Centre, Lisbon, Portugal; Department of Hematology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands; Division of Medical Oncology, National Cancer Institute, Aviano, Italy; Department of Hematology, Institut Gustave Roussy, Villejuif, France